ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 13, 2015
Beginning of BlackBerry Turnaround?
A few recent developments could be pointing to a turnaround at BlackBerry, or is it too little too late?
Nov 12, 2015
Alibaba Crushes Singles’ Day Records
Alibaba reported record gross merchandise volume on Singles’ Day 2015.
Nov 12, 2015
Investors Punish Priceline for Conservative Guidance
Despite the company reporting solid fundamental results in the third quarter of 2015, Priceline’s shares have taken a beating as a result of the conservative outlook management issued for the fourth quarter.
Nov 11, 2015
5 Reasons to Consider Not Owning McDonald’s
Let’s walk through reasons why we don’t think the fast-food giant will be an outperformer in coming years.
Nov 8, 2015
Dividend Increases/Decreases for the Week Ending November 6
Let's take a look at companies raising/lowering their dividends this week.
Nov 5, 2015
Catching Up With Some of Our Best Ideas
Let’s take a look at the recent performance of a few companies within the Best Ideas Newsletter portfolio.
Nov 3, 2015
US Oil Majors
Lower price realizations for major oil producers continue to pressure financial results. Though refining and chemical margins have improved, big oil exploration and production remains under significant pressure.
Oct 30, 2015
Strong Performance from Big Tobacco in Third Quarter
A number of big tobacco firms performed well in the third quarter of 2015, but industry-wide cigarette volume continued its downward trend.
Oct 28, 2015
Around the Horn in Biotech/Pharma: 3Q Earnings Review
Abbott, Biogen, Bristol-Myers, Eli Lilly, Gilead, GlaxoSmithKline, Merck, Pfizer…
Oct 26, 2015
If It Happened to AbbVie, Could It Also Happen to Gilead?
Recent news concerning AbbVie’s hepatitis C drugs caused a severe decline in the company’s share price. Could such an event happen to Gilead?


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.